TearLab

Using TearLab's first point-of-care ophthalmic in vitro diagnostic platform, users can add data to their reports to guide the diagnosis and management of the ocular surface. With precise and predictable information available in just a few seconds, doctors can assess the health of the tear film, detect abnormal osmolarity, and inform patients about treatment plans based on severity while managing their condition.